Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-29 @ 6:54 AM
Study NCT ID:
NCT01799395
Status:
TERMINATED
Last Update Posted:
2017-09-12
First Post:
2013-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
Sponsor:
Maggiore Bellaria Hospital, Bologna
Organization:
Study Overview
Official Title:
Prevalence, Incidence and Predictors of Central Airway Obstruction in Patients With Advanced Lung Cancer
Status:
TERMINATED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Staff constraints made it impossibile to enroll consecutive patients, making the sample not representative of the true cancer population
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lung cancer may cause central airway obstruction through several different mechanisms (invasion by the primary tumor, invasion by metastatic lymph nodes, airway metastasis).
The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.
The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: